Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Calvo

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Oncotarget|May 27, 2015
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentDirena Alonso-Curbelo, Lisa Osterloh, Estela Cañón, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Nature Cancer|March 29, 2025
Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockadeXavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, et al.
Trials|October 31, 2019
European survey on national training activities in clinical researchA Magnin, V Cabral Iversen, G Calvo, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Osteoarthritis and Cartilage|January 11, 2005
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritisR D Altman, E Abadie, B Avouac, et al.
Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.
Nature Communications|December 23, 2017
Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1Metehan Cifdaloz, Lisa Osterloh, Osvaldo Graña, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Oncotarget|May 27, 2015
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentDirena Alonso-Curbelo, Lisa Osterloh, Estela Cañón, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Nature Cancer|March 29, 2025
Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockadeXavier Catena, Marta Contreras-Alcalde, Naiara Juan-Larrea, et al.
Trials|October 31, 2019
European survey on national training activities in clinical researchA Magnin, V Cabral Iversen, G Calvo, et al.
Cancer Cell|August 4, 2009
Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cellsDamià Tormo, Agnieszka Checińska, Direna Alonso-Curbelo, et al.
Osteoarthritis and Cartilage|January 11, 2005
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritisR D Altman, E Abadie, B Avouac, et al.
Cancer Cell|December 25, 2018
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic FactorsPanagiotis Karras, Erica Riveiro-Falkenbach, Estela Cañón, et al.
Nature Communications|December 23, 2017
Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1Metehan Cifdaloz, Lisa Osterloh, Osvaldo Graña, et al.
Pageof 16